Literature DB >> 29527284

A mini-library system to investigate non-essential residues of lipid-phosphatidylserine (PS) binding peptide-peptoid hybrid PPS1.

Satya Prakash Shukla1, D Gomika Udugamasooriya1,2.   

Abstract

We recently identified a peptide-peptoid hybrid, PPS1, which specifically recognized lipid-phosphatidylserine (PS). PPS1 consists of distinct positively charged and hydrophobic residue-containing regions. PPS1 monomer was inactive, but the dimeric form, PPS1D1, displayed strong cytotoxicity for lung cancer cells compared to normal cells in vitro, and reduced the tumor growth in vivo. The minimum pharmacophore of PPS1D1 showed that the first (methionine) and fourth (N-lysine) residues were not important for PPS1D1 cytotoxic activity. In this study, we further investigated these two residues, in particular the fourth residue that lies between the most important four residue hydrophobic region and two positively charged residues, to determine whether replacements of these moieties could gain activity improvements, or render PPS1D1 totally insensitive for binding recognition. The positively charged fourth residue N-lysine was replaced with the substituents having varied physiochemical properties, such as aromatic-hydrophobic, aliphatic-alicyclic, heterocyclic, and negatively charged residues, developing a mini-library of 39 derivatives. The standard 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) colorimetric and/or the calcein AM cell viability assays performed on HCC4017 lung cancer cells indicated that the fourth position of PPS1D1 was insensitive to most changes, except reversal to the negative charge significantly affected the activity. This observation may be due to the neutralization of the nearby positively charged residue that is essential for binding. In addition, shortening each monomeric sequence by eliminating the methionine at the first position did not affect the activity.

Entities:  

Year:  2017        PMID: 29527284      PMCID: PMC5841255          DOI: 10.1039/C7MD00372B

Source DB:  PubMed          Journal:  Medchemcomm        ISSN: 2040-2503            Impact factor:   3.597


  19 in total

Review 1.  Aminophospholipid asymmetry: A matter of life and death.

Authors:  Krishnakumar Balasubramanian; Alan J Schroit
Journal:  Annu Rev Physiol       Date:  2002-05-01       Impact factor: 19.318

2.  A comprehensive lipid binding and activity validation of a cancer-specific peptide-peptoid hybrid PPS1.

Authors:  Tanvi J Desai; D Gomika Udugamasooriya
Journal:  Biochem Biophys Res Commun       Date:  2017-03-18       Impact factor: 3.575

3.  Phosphatidylserine is a marker of tumor vasculature and a potential target for cancer imaging and therapy.

Authors:  Sophia Ran; Philip E Thorpe
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-12-01       Impact factor: 7.038

4.  Appearance of phosphatidylserine on apoptotic cells requires calcium-mediated nonspecific flip-flop and is enhanced by loss of the aminophospholipid translocase.

Authors:  D L Bratton; V A Fadok; D A Richter; J M Kailey; L A Guthrie; P M Henson
Journal:  J Biol Chem       Date:  1997-10-17       Impact factor: 5.157

Review 5.  Tumor heterogeneity: causes and consequences.

Authors:  Andriy Marusyk; Kornelia Polyak
Journal:  Biochim Biophys Acta       Date:  2009-11-18

Review 6.  Membrane lipids: where they are and how they behave.

Authors:  Gerrit van Meer; Dennis R Voelker; Gerald W Feigenson
Journal:  Nat Rev Mol Cell Biol       Date:  2008-02       Impact factor: 94.444

Review 7.  Membrane asymmetry.

Authors:  J E Rothman; J Lenard
Journal:  Science       Date:  1977-02-25       Impact factor: 47.728

8.  In search of a novel target - phosphatidylserine exposed by non-apoptotic tumor cells and metastases of malignancies with poor treatment efficacy.

Authors:  Sabrina Riedl; Beate Rinner; Martin Asslaber; Helmut Schaider; Sonja Walzer; Alexandra Novak; Karl Lohner; Dagmar Zweytick
Journal:  Biochim Biophys Acta       Date:  2011-07-26

Review 9.  Tumour heterogeneity and cancer cell plasticity.

Authors:  Corbin E Meacham; Sean J Morrison
Journal:  Nature       Date:  2013-09-19       Impact factor: 49.962

10.  Identification of lipid-phosphatidylserine (PS) as the target of unbiasedly selected cancer specific peptide-peptoid hybrid PPS1.

Authors:  Tanvi J Desai; Jason E Toombs; John D Minna; Rolf A Brekken; Damith Gomika Udugamasooriya
Journal:  Oncotarget       Date:  2016-05-24
View more
  2 in total

1.  Unbiased peptoid cell screen identifies a peptoid targeting newly appeared cell surface vimentin on tumor transformed early lung cancer cells.

Authors:  Satya Prakash Shukla; Haowen Zhang; Bingliang Fang; John D Minna; D Gomika Udugamasooriya
Journal:  Bioorg Med Chem       Date:  2022-02-15       Impact factor: 3.461

Review 2.  Phosphatidylserine: The Unique Dual-Role Biomarker for Cancer Imaging and Therapy.

Authors:  Ahmet Kaynak; Harold W Davis; Andrei B Kogan; Jing-Huei Lee; Daria A Narmoneva; Xiaoyang Qi
Journal:  Cancers (Basel)       Date:  2022-05-21       Impact factor: 6.575

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.